- argenx SE at Barclays Global Healthcare Conference TranscriptMar 12, 2024
- Q4 2023 argenx SE Earnings Call TranscriptFeb 29, 2024€380Earnings
- argenx SE at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- argenx SE Reports Topline Results from ADDRESS Study of Efgartigimod SC in Pemphigus TranscriptDec 20, 2023
- argenx SE Investor Call TranscriptNov 28, 2023
- Q3 2023 argenx SE Earnings Call TranscriptOct 31, 2023€468.3Earnings
- argenx SE at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- argenx SE at Citi BioPharma Conference TranscriptSep 06, 2023
- Q2 2023 argenx SE Earnings Call TranscriptJul 27, 2023€477.8Earnings
- argenx SE To Discuss the Adhere Results TranscriptJul 17, 2023
- argenx SE To Discuss Drug Administration Approval of VYVGART TranscriptJun 21, 2023
- argenx SE at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 argenx SE Earnings Call TranscriptMay 04, 2023€352.7Earnings
- argenx SE at TD Cowen Health Care Conference TranscriptMar 06, 2023
- Q4 2022 argenx SE Earnings Call TranscriptMar 02, 2023€347.3Earnings
- argenx SE Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 09:00 AM TranscriptJan 09, 2023
- argenx SE at Piper Sandler Healthcare Conference TranscriptNov 30, 2022
- argenx SE at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Q3 2022 argenx SE Earnings Call TranscriptOct 27, 2022€359.1 (-7.78%)Earnings
- Q2 2022 argenx SE Earnings Call TranscriptJul 28, 2022€361.9 (+1.17%)Earnings
- argenx SE at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- argenx SE at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 argenx SE Earnings Call TranscriptMay 05, 2022€304.8 (+12.64%)Earnings
- argenx SE Topline Phase 3 Data From ADAPT-SC Study Call TranscriptMar 22, 2022
- argenx SE at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Q4 2021 argenx SE Earnings Call TranscriptMar 03, 2022€264.4Earnings
- argenx SE at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- argenx SE To Discuss FDA Approval Call TranscriptDec 17, 2021
- Q3 2021 argenx SE Earnings Call TranscriptOct 28, 2021€240.5 (+0.25%)Earnings
- argenx SE at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 argenx SE Earnings Call TranscriptJul 29, 2021€252.5 (-1.75%)Earnings
- argenx SE virtual R&D Day Call TranscriptJul 20, 2021
- argenx SE at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Q1 2021 argenx SE Earnings Call TranscriptMay 14, 2021€221 (+1.89%)Earnings
- argenx SE Presents At Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Full Year 2020 argenx SE Earnings Call TranscriptMar 04, 2021€254.4 (-5.07%)Earnings
- argenx SE - Special Call TranscriptFeb 01, 2021
- argenx SE at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- argenx SE at Stifel Virtual Healthcare Conference TranscriptNov 17, 2020
- Q3 2020 argenx SE Earnings Call TranscriptOct 22, 2020€212.4 (-3.63%)Earnings
- argenx SE at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- argenx SE at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Half Year 2020 argenx SE Earnings Call TranscriptJul 30, 2020Earnings
- argenx SE at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- argenx SE Announces Positive Topline Results from Phase 3 ADAPT Trial of Efgartigimod in Patients with Generalized Myasthenia Gravis - Call TranscriptMay 26, 2020
- Q1 2020 argenx SE Earnings and Business Update Call TranscriptMay 14, 2020
- argenx SE at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q4 2019 argenx SE Earnings Call TranscriptFeb 27, 2020Earnings
- argenx SE at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- argenx SE at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 argenx SE Earnings Call TranscriptAug 01, 2019Earnings
- argenx SE - Special Call TranscriptMay 22, 2019
- Q4 2018 argenx SE Earnings Call TranscriptFeb 28, 2019Earnings
argenx SE at Morgan Stanley Healthcare Conference Transcript
It's only 10:30. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Just quickly before we get started with argenx, I just need to read a quick disclosure statement.
Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.
So very pleased to have with me argenx and Tim, who's the CEO, with me here. So Tim, I don't know if you want to make any opening comments. But if not, we'll jump right into Q&A.
Let's go straight into Q&A. Thanks for having us today, Matthew.
Questions & Answers
Yes. So I thought we'd start with efgartigimod, and there are a lot of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)